A Special Announcement from the Treatment Advocacy Center Hello John, I hope that you had a meaningful Labor Day and that you and your loved ones are continuing to weather this pandemic. As you know, Treatment Advocacy Center’s former executive director, John Snook, departed last January, at which time the Board of Directors appointed longtime staffer Lisa Dailey as acting executive director. Since that time, Lisa has only confirmed the wisdom of our choice. For the past eight months, she has successfully steered Treatment Advocacy Center through a leadership transition and helped us survive and thrive in the midst of a global health crisis. At a time when treatment reform has never been more urgent, Lisa and the talented Treatment Advocacy Center team she leads have been keeping the public’s attention focused and keeping our government leaders accountable. For all those reasons, the Board of Directors is convinced that a further search for a permanent leader for our organization is not necessary. I am, therefore, very pleased to share with you the news that the Board of Directors has voted to offer the position of executive director to Lisa, and that she has accepted our offer. Here is a link to the press release on our website announcing Lisa Dailey as our new executive director. Learn more about Lisa in this in-depth interview for the Spring 2021 issue of Catalyst. On behalf of the entire Board of Directors, please join me in congratulating Lisa on her new role! Treatment Advocacy Center is indeed in good hands. Thank you for your ongoing support of our mission. Sincerely, Dr. Michael Knable President Treatment Advocacy Center Board of Directors Thank you for your continued support of the Treatment Advocacy Center. Donate Treatment Advocacy Center | Website ‌ ‌ ‌ ‌ Treatment Advocacy Center | 200 N Glebe Rd, Ste 801, Arlington, VA 22203 Unsubscribe [email protected] Update Profile | Constant Contact Data Notice Sent by [email protected] powered by Try email marketing for free today!